Anti-tumor activities of the new oral pan-RAF inhibitor, TAK-580, used as monotherapy or in combination with novel agents in multiple myeloma

Many RAS pathway inhibitors, including pan-RAF inhibitors, have shown significant anti-tumor activities in both solid and hematological tumors. The pan-RAF inhibitor, TAK-580, is a representative of the novel RAF inhibitors that act by disrupting RAF homo- or heterodimerization. In this study, we ex...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Suzuki, Rikio, Kitamura, Yuka, Nakamura, Yoshihiko, Akashi, Hibiki, Ogawa, Yoshiaki, Kawada, Hiroshi, Ando, Kiyoshi
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646837/
https://ncbi.nlm.nih.gov/pubmed/33216827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados